bioAffinity Technologies, Inc. (BIAF) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for bioAffinity Technologies, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.14x | -1.22x | -1.62x | -0.88x | -3.51x | -8.42x |
| P/B Ratio | 0.28x | 4.24x | 2.65x | 0.65x | -1.41x | -4.06x |
| P/S Ratio | 0.33x | 1.18x | 5.08x | 1498.73x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 23.2% | 36.1% | 31.3% | 90.3% | 0.0% | 0.0% |
| Operating Margin | -171.6% | -95.6% | -314.9% | -83511.5% | 0.0% | 0.0% |
| Net Margin | -242.0% | -96.6% | -313.5% | -169771.2% | 0.0% | 0.0% |
| EBITDA Margin | -163.4% | -89.0% | -301.3% | -116777.7% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.60x | 0.87x | 1.77x | 10.50x | 0.11x | 0.01x |
| Quick Ratio | 2.58x | 0.86x | 1.76x | 10.50x | 0.11x | 0.01x |
| Leverage | ||||||
| Debt/Equity | 0.16x | 0.58x | 0.33x | 0.02x | -0.72x | -0.66x |
YoY = year-over-year change. Source: FMP..